Spun out of research by a Penn State University professor, De Novo DNA is structured around development of software for genetic research. The user-friendly software makes specific predictions to improve the performance of genetic systems. Customers develop next-generation biofuels, renewable materials, recombinant enzymes, and medical therapeutics using De Novo's software. This software is available for use directly on the firm's website. The firm's continuing mission is to decode the rules of life, develop predictive and accurate biophysical models, and to accelerate biotech R&D across the world.
